J&J reports one-year ICOTYDE psoriasis treatment data shows sustained results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. SPY
4. ABBV
5. META
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to J&J reports one-year ICOTYDE psoriasis treatment data shows sustained results
Johnson & Johnson (NYSE: JNJ) Delayed: 239.08 --0 (-0%)
Previous Close $239.08    52 Week High $126.07 
Open $239.08    52 Week Low $94.28 
Day High $239.08    P/E 49.70 
Day Low $239.08    EPS $4.81 
Volume 1,550